ALDH1L1
ALDH1L1 (aldehyde dehydrogenase 1 family member L1, also known as FDH, FTHFD and 10-fTHF) is a cytosolic enzyme that converts 10-formyltetrahydrofolate to tetrahydrofolate in an NADP(+)-dependent reaction. It belongs to the aldehyde dehydrogenase family. Browse Assay Genie's current range of ALDH1L1 research reagents below, or read on for the biology behind the target.
ALDH1L1 is a cytosolic 10-formyltetrahydrofolate dehydrogenase. It catalyses the NADP(+)-dependent conversion of 10-formyltetrahydrofolate to tetrahydrofolate and carbon dioxide, with NADPH produced in the reaction. The enzyme may also show NADP(+)-dependent aldehyde dehydrogenase activity towards formaldehyde, acetaldehyde, propionaldehyde and benzaldehyde.
The human ALDH1L1 gene encodes a protein that sits in the aldehyde dehydrogenase family; within the HGNC classification it belongs to the aldehyde dehydrogenases gene group, and UniProt places it in the ALDH1L subfamily, with the aldehyde dehydrogenase-like region in the C-terminal section. UniProt reports its subcellular location as the cytosol. Mouse and rat orthologs are both designated Aldh1l1. The gene locus has an overlapping antisense transcript on the opposite strand, and alternative splicing results in multiple transcript variants.
The protein has also been named formyltetrahydrofolate dehydrogenase, and the symbol FDH or FTHFD appears in older literature. NCBI Gene reports that loss of function or expression of the gene is associated with decreased apoptosis, increased cell motility and cancer progression, which makes ALDH1L1 a recurring subject in folate metabolism and cancer biology. Researchers studying this target often look at the ALDH1L1 protein and its expression alongside other members of the aldehyde dehydrogenase family.
ALDH1L1 converts 10-formyltetrahydrofolate to tetrahydrofolate and carbon dioxide, so it is a central enzyme for studying cytosolic folate pathways.
Loss of ALDH1L1 function or expression is associated with decreased apoptosis, increased cell motility and cancer progression.
The enzyme may act on aldehydes including formaldehyde, acetaldehyde, propionaldehyde and benzaldehyde, linking it to aldehyde dehydrogenase research.
The ALDH1L1 reaction is NADP(+)-dependent and generates NADPH, which places the enzyme within studies of cellular redox cofactors.
ALDH1L1 is a cytosolic enzyme that catalyses the NADP(+)-dependent conversion of 10-formyltetrahydrofolate to tetrahydrofolate and carbon dioxide. It may also oxidise aldehydes such as formaldehyde, acetaldehyde, propionaldehyde and benzaldehyde.
The protein is called cytosolic 10-formyltetrahydrofolate dehydrogenase. Aliases and previous symbols include 10-fTHF, FDH and FTHFD, and earlier names include formyltetrahydrofolate dehydrogenase and aldehyde dehydrogenase 1 family, member L1. Alternative splicing gives multiple transcript variants.
Yes. Mouse and rat both have an ortholog named Aldh1l1, so the gene can be studied in rodent models; check the datasheet of any product for its validated reactivity. NCBI Gene links loss of its function or expression to decreased apoptosis, increased cell motility and cancer progression.
Other members of the aldehyde dehydrogenase family that are relevant to folate, aldehyde and NAD(P)-dependent metabolism research.
Gene and protein annotations from HGNC, NCBI Gene and UniProt O75891; product specifications from Assay Genie datasheets.